Pityriasis versicolor: a review of pharmacological treatment options.
Pityriasis versicolor is a common disorder of the skin, which is characterised by scaly hypo- or hyperpigmented lesions on the body. The lipophilic yeast, Malassezia, is considered to be the aetiological agent of this disease. A number of treatment options, both topical and systemic, have been shown to be effective. A critical evaluation of treatment options is presented.
Gupta
Aditya K
AK
University of Toronto, and the Sunnybrook and Womens' College Health Sciences Center (Sunnybrook site), Toronto, Ontario, Canada. agupta@execulink.com
Kogan
Nataly
N
Batra
Roma
R
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D006801:Humans; D008290:Malassezia / Q000187:drug effects*; D055502:Secondary Prevention; D012867:Skin / Q000187:drug effects* / Q000382:microbiology / Q000473:pathology; D014010:Tinea Versicolor / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control
D000935:Antifungal Agents